Breaking News

Global Lung Cancer Liquid Biopsy Market Analysis To Grow At CAGR Of 17.15% Over period 2017-2021

img

“The Latest Research Report Global Lung Cancer Liquid Biopsy Market 2017-2021 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

A liquid biopsy helps to identify free-floating tumor DNA (also known as circulating DNA) within the blood sample of a patient. Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. It is observed that the use of a liquid biopsy to identify carcinogenic cells of lungs will help in the early diagnosis of lung cancer.

Technavios analysts forecast the global lung cancer liquid biopsy market to grow at a CAGR of 17.15% during the period 2017-2021.

Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/1476374

Covered in this report

The report covers the present scenario and the growth prospects of the global lung cancer liquid biopsy market for 2017-2021. To calculate the market size, the report considers the sales and values of lung cancer liquid biopsy assays.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio’s report, Global Lung Cancer Liquid Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Biocept

Exosome Diagnostics

F. Hoffmann-La Roche

QIAGEN

Other prominent vendors

AccuraGen

Agena Bioscience

BARD1

BGI

Biodesix

Bio-Rad Laboratories

Cancer Genetics

CellMax Life

Circulogene

CLEARBRIDGE BIOMEDICS

Cynvenio Biosystems

EntroGen

Epic Sciences

Epigenomics

Fluxion Biosciences

Freenome

Gencurix

Genetracer Biotech

Genomic Health

Grail

Guardant Health

HeliTec

Inivata

Lonza

MedGenome

Nanoview Diagnostics

Natera

Novogene

OncoCyte

OncoDNA

Pathway Genomics

Personal Genome Diagnostics

Predicine

Shuwen Biotech

Sysmex

Thermo Fisher Scientific

Transgenomic

Trovagene

Market driver

Rising incidence of lung cancer

For a full, detailed list, view our report

Browse Complete Report with TOC @ https://www.marketresearchreports.biz/reports/1476374/global-lung-cancer-liquid-biopsy-market-research-reports/toc

Market challenge

High cost of lab testing procedure

For a full, detailed list, view our report

Market trend

Vendors’ focus on clinical trials

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

Market outline

PART 05: MARKET LANDSCAPE

Market ecosystem

Market segmentation analysis

PART 06: MARKET SIZING

Market definition

Market sizing 2016

Market size and forecast 2016-2021

PART 07: FIVE FORCES ANALYSIS

PART 08: MARKET SEGMENTATION BY PRODUCT

Segmentation by product

Comparison by product

Global lung cancer liquid biopsy market by CTCs and ctDNA

Global lung cancer liquid biopsy market by exosomes and RNA

Market opportunity by product

PART 09: MARKET SEGMENTATION BY END-USER

Segmentation by end-user

Market share by end-user

Clinical diagnostic laboratories

Hospitals and clinics

Physicians’ office laboratories

View Sample PDF @

https://www.marketresearchreports.biz/reports/1476374/global-lung-cancer-liquid-biopsy-market-research-reports.pdf

PART 10: REGIONAL LANDSCAPE

Geographical segmentation

Regional comparison

Lung cancer liquid biopsy market in Americas

Lung cancer liquid biopsy market in EMEA

Lung cancer liquid biopsy market in APAC

Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 13: MARKET TRENDS

Growing partnership agreements

Vendors’ focus on clinical trials

Application of liquid biopsy for personalized treatment

PART 14: VENDOR LANDSCAPE

Competitive landscape

PART 15: KEY VENDOR ANALYSIS

Biocept

Exosome Diagnostics

F. Hoffmann-La Roche

QIAGEN

Key companies to watch

Other prominent vendors

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Email

Also Read:  Power Rental Global Market Overview with detailed analysis, Competitive landscape Forecast 2023

Go to website

WP Facebook Auto Publish Powered By : XYZScripts.com